132 results on '"Genentech Inc. -- Forecasts and trends"'
Search Results
2. Immune Thrombocytopenia Purpura Market to Expand Significantly by 2034, States DelveInsight Report | Biotest, Argenx, Sanofi, Principia Biopharma, Rigel Pharma, Principia Biopharma, GlaxoSmithKline
3. Vascular Malformations Market to Grow Substantially by 2034, Assesses DelveInsight | Key Companies - ARTham Therapeutics, Neurelis, Protara Therapeutics, Recursion, Genentech, Vascular Therapies, Palvella Therapeutics
4. HER2-Negative Breast Cancer Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | Genentech, Inc., AstraZeneca, Novartis
5. Multiple Myeloma Market Trends & Forecasts 2032 | Drug Pipeline, FDA Approvals, and companies by DelveInsight | GSK, BMS, Bluebird bio, Oncopeptides AB, Secura Bio, Amgen, Takeda, Sanofi, Janssen
6. Choroidal Neovascularization Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Abbvie, Sylentis, Ixoberogene soroparvovec, Novartis, Roche
7. CD-20 Market to Witness Significant Growth During the Study Period (2019-2032), Assesses DelveInsight | Major Players - TG Therapeutics, Genentech (Roche), Genmab, Abbvie, Regeneron
8. Relapsing|Refractory Multiple Myeloma Market to Observe Stupendous Growth by 2032, Estimates DelveInsight | Leading Companies - Bristol-Myers Squibb, Allogene Therapeutics, Genentech, Pfizer, Ionis Pharmaceuticals, AbbVie, Amgen
9. Relapsing/Refractory Multiple Myeloma Market to Observe Stupendous Growth by 2032, Estimates DelveInsight | Leading Companies - Bristol-Myers Squibb, Allogene Therapeutics, Genentech, Pfizer, Ionis Pharmaceuticals, AbbVie, Amgen
10. Arteriovenous Malformations Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Genentech, Micro Therapeutics Inc., Shire, Eisai Co., Ltd
11. Systemic Sclerosis-associated Interstitial Lung Disease Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | MERCK, GSK, Genentech
12. Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
13. Cutaneous Squamous Cell Carcinoma Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Key Players - Genentech, Incyte, Boehringer Ingelheim, Merck, Regeneron, Sanofi, Morphogenesis, NeoImmuneTech
14. Chronic Obstructive Pulmonary Disease Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron
15. Choroidal Neovascularization Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | Abbvie, Sylentis, Ixoberogene soroparvovec, Novartis, Hoffmann-La Roche
16. Acute Lymphocytic Leukemia Market to Accelerate Substantially by 2032, Assesses DelveInsight | Key Companies in the Market - Beam, Pfizer, Genentech, AbbVie, Fate, Roche, Ascentage, Janssen, Jazz, ADC, Kymera, Syndax, ImmunoGen
17. Cervical Cancer Market Size is Likely to Increase, Examines DelveInsight | Key Companies in the Market - Gilead, Roche, Genentech, Iovance, Bristol-Myers Squibb, Exelixis, Xencor, Merck, EMD Serono, Pfizer, Fusion, AstraZeneca
18. Cervical Cancer Market Size is Likely to Increase, Examines DelveInsight | Key Companies in the Market - Gilead, Roche, Genentech, Iovance, Bristol-Myers Squibb, Exelixis, Xencor, Merck, EMD Serono, Pfizer, Fusion, AstraZeneca
19. Hemophilia Market to Proliferate Immensly, Predicts DelveInsight | Key Companies to Look Out for - Pfizer, Sanofi, CSL Behring, Freeline, Genentech, Shire, Spark, Novo Nordisk, Sangamo, UBI, uniQure
20. Ovarian Clear Cell Carcinoma Market expected to rise, Genentech, GlaxoSmithKline, AstraZeneca, Clinigen Group, Novartis, Clovis Oncology, Ortho Biotech, Bristol-Myers Squibb, expected to drive market
21. Cutaneous Squamous Cell Carcinoma Market expected to rise, Incyte Corporation, Shanghai Henlius Biotech, Novartis, Rakuten Medical, Morphogenesis, Genentech, Berg Pharma, I-MAB Biopharma, Roche
22. Basal Cell Carcinoma Market to Observe Impressive Growth During the Forecast Period (2022-2032), Evaluates DelveInsight | Novartis, MEDA Pharma, Genentech, Inc., Galderma R&D, Hoffmann-La Roche
23. Global Protein Therapeutics Market Report 2023: Development of Plasma Derived Therapies Drives Growth
24. Sinusitis Market to Register Stunning Growth, Estimates DelveInsight | Key Players in the Market - Optinose, GeneOne Life Science, Lyra, Sanofi, Regeneron, Genentech, AstraZeneca, Sanofi, Bayer, Pfizer
25. Metastatic Renal Cell Carcinoma Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2022-2032), Analyzes DelveInsight | Key Companies - AstraZeneca, Genentech, Sumitomo
26. 30+ Active Companies working to develop 35+ Pipeline Therapies for Food Allergy Treatment Landscape | Major Companies - Merck, Genentech, Novartis, and Others
27. Endometrial Cancer Market Growing Significantly | AstraZeneca, Karyopharm, Evergreen therapeutics, ImmunoGen, Inc., Merck, Tesaro, Inc., Abbott, Roche, Chimerix, Bayer, ImmunoGen, Inc., Incyte, Eli Lilly, Gilead, Genentech Expected to Boost
28. Global Oncology Drugs Market Size & Analysis
29. Lupus Nephritis Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies - Hoffmann-La Roche, Genentech, Inc., Astrazeneca, Equillium
30. Diabetic Retinopathy Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Key Companies - Genentech, Inc., Regeneron Pharmaceuticals
31. Antiglaucoma Drugs Global Market Report 2023
32. Global Genitourinary Drugs Market Report 2022 to 2027: Featuring Allergan, Antares Pharma, Bayer and Novartis Among Others
33. Antiglaucoma Drugs Global Market Report 2023
34. Genitourinary Drugs Global Market 2022: Sector to Reach $35.5 Billion by 2027 at a CAGR of 2.01%
35. Genitourinary Drugs Global Market 2022: Sector to Reach $35.5 Billion by 2027 at a CAGR of 2.01%
36. Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) Market Report (2022 to 2030) - Pfizer Inc., Novartis AG, Genentech, Inc., GlaxoSmithKline Plc. and LFB Biomedicaments
37. Global Hemophilia Treatment Market Report 2022 to 2030 - Featuring Ferring, Kedrion, Octapharma and Novo Nordis Among Others
38. Worldwide Hemophilia Treatment Industry to 2030 - by Product, Hemophilia Type and Region
39. Worldwide Hemophilia Treatment Industry to 2030 - by Product, Hemophilia Type and Region
40. Global Hemophilia Treatment Market Report 2022 to 2030 - Featuring Ferring, Kedrion, Octapharma and Novo Nordis Among Others
41. 40+ Leading Thyroid Cancer Pipeline Companies are working to improve the treatment landscape
42. Food Allergy Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
43. Spinal Muscular Atrophy Treatment Market Worth $18.0 Billion by 2030: Grand View Research, Inc
44. Thyroid Cancer Pipeline Landscape Analysis: 40+ Key Players & 40+ Pipeline Drugs
45. Lupus Nephritis Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies - Hoffmann-La Roche, Genentech, Astrazeneca, Equillium, Novartis
46. Global Patient Access/Front-end RCM Solutions Market Analysis Report 2022: Growing Focus on Integration Platform as a Service (IPaaS) & Budgetary Constraints and Cost-Cutting Measures in Europe
47. USD 1.31 Bn growth for Urticaria Drugs Market through 2026: Analysing growth for Pharmaceuticals - Technavio
48. Global Acquired von Willebrand Disease (AvWD) Treatment Market Report 2022-2030 Featuring Key Players - Novo Nordisk A|S, Genentech, Inc., F. Hoffman-La Roche AG, Sanofi SA
49. Global Acquired von Willebrand Disease (AvWD) Treatment Market Report 2022-2030 Featuring Key Players - Novo Nordisk A/S, Genentech, Inc., F. Hoffman-La Roche AG, Sanofi SA
50. $7.9 Billion Worldwide Human Growth Hormone Industry to 2027 - Featuring Genentech, Ipsen, Merck and Novartis Among Others
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.